Spiraprilat

Spiraprilat
Identifiers
	IUPAC name (8S)-7-[(2S)-2-{[(1S)-1-Carboxy-3-phenylpropyl]amino}propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid;
CAS Number	83602-05-5 ;
PubChem CID	3033702;
IUPHAR/BPS	6576;
ChemSpider	2298317;
UNII	QS56V5Y7EC;
ChEBI	CHEBI:141522;
ChEMBL	ChEMBL579;
CompTox Dashboard (EPA)	DTXSID30232453 ;
Chemical and physical data
Formula	C20H26N2O5S2
Molar mass	438.56 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3;
	InChI InChI=1S/C20H26N2O5S2/c1-13(21-15(18(24)25)8-7-14-5-3-2-4-6-14)17(23)22-12-20(28-9-10-29-20)11-16(22)19(26)27/h2-6,13,15-16,21H,7-12H2,1H3,(H,24,25)(H,26,27)/t13-,15-,16-/m0/s1; Key:FMMDBLMCSDRUPA-BPUTZDHNSA-N;

Spiraprilat is the active metabolite of spirapril.^[1]

References

^ Noble S, Sorkin EM (May 1995). "Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension". Drugs. 49 (5): 750–66. doi:10.2165/00003495-199549050-00008. PMID 7601014. S2CID 195691037.

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.